H.C. Wainwright Reiterates Buy Rating on Dogwood Therapeutics, Inc. (DWTX)

September 2, 2026 7:08 AM EDT Send to a Friend
H.C. Wainwright analyst Sean Lee reiterated a Buy rating and $12.00 price target on Dogwood Therapeutics, Inc. (NASDAQ: DWTX).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login